The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events

Kidney International

Volumn 69, Issue 3, 2006, Pages 588-595

  Hjelmesaeth J ^a,b   Hartmann, A ^a   Leivestad, T ^a   Holdaas, H ^a   Sagedal, S ^a   Olstad, M ^a   Jenssen, T ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b VESTFOLD HOSPITAL TRUST   (Norway)

Author keywords

C reactive protein; Cardiovascular disease; Death; Diabetes mellitus; Kidney transplantation

Indexed keywords

CREATININE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART DEATH; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; ONSET AGE; OVERALL SURVIVAL; PATIENT ASSESSMENT; POSTTRANSPLANTATION DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; REGISTER; SURVIVAL RATE;

ADULT; AGED; C-REACTIVE PROTEIN; CAUSE OF DEATH; CREATININE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; FEMALE; HUMANS; INCIDENCE; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 31544450765     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000116     Document Type: Article

References (45)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S37-S42.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
3. Ceriello A. Postprandial hyperglycemia and diabetes complications. Is it time to treat? Diabetes 2005; 54: 1-7.
4. Hanefeld M, Fischer S, Julius U et al. Risk factors for myocardial infarction and death in newly detected NIDDM: The diabetes intervention study, 11-year follow up. Diabetologia 1996; 39: 1577-1583.
5. Esposito K, Giugliano D, Nappo F, Marfella R. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004; 110: 214-219.
6. The DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes association diagnostic criteria. Lancet 1999; 354: 617-621.
7. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106: 453-458.
8. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
9. Lindholm A, Albrechtsen D, Frödin L et al. Ischemic heart disease. Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60: 451-457.
10. Kasiske BL, Guijarro C, Massy ZA et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165.
11. Aakhus S, Dahl K, Widerøe TE. Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up. Clin Transplant 2004; 18: 596-604.
12. Aker S, Ivens K, Guo Z et al. Cardiovascular complications after renal transplantation. Transplant Proc 1998; 30: 2039-2042.
13. Jardine AG, Holdaas H, Fellstrom B et al. ALERT Study Investigators: Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT study. Am J Transplant 2004; 4: 988-995.
14. Montori VM, Basu A, Erwin PJ et al. Posttransplantation diabetes. A systematic review of the literature. Diabetes Care 2002; 25: 583-592.
15. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications and management. Am J Kidney Dis 2004; 43: 953-965.
16. Hjelmesæth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979-983.
17. Ekstrand AV, Eriksson JG, Gronhagen-Riska C et al. Insulin resistance and insulin deficiency in the pathogenesis of posttransplant diabetes in man. Transplantation 1992; 53: 563-569.
18. Hjelmesæth J, Hagen M, Hartmann A et al. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant 2002; 16: 389-396.
19. Cosio FG, Pesavento TE, Kim S et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440-1446.
20. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185.
21. Revanur VK, Jardine AG, Kingsmore DB et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 89-94.
22. Lentine KL, Brennan DC, Schnitzler A. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496-506.
23. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 2005; 79: 438-443.
24. Miles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380-384.
25. Hjelmesæth J, Hartmann A, Kofstad J et al. Tapering off prednisolone and cyclosporin the first year after transplantation: the effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: 829-835.
26. Gaston RS, Basadonna G, Cosio FG et al. Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis 2004; 44: 529-542.
27. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
28. World Health Organization Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation. WHO: Geneva, 1999.
29. Winkelmayer WC, Lorenz M, Kramar R et al. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant 2004; 4: 1148-1154.
30. Shinohara K, Shoji T, Emoto M et al. Insulin resistance is an independent risk factor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900.
31. Shimizu M, Iino Y, Terashi A. Improvement of insulin sensitivity after renal transplantation measured by a glucose clamp technique. Nippon Ika Daigaku Zasshi 1998; 65: 50-54.
32. Nam JH, Mun JI, Kim SI et al. β-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71: 1417-1423.
33. Holdaas H, Fellstrom B, Jardine AG et al. Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebo-controlled trial. Lancet 2003; 361: 2024-2031.
34. van Dijk PC, Jager KJ, de Charro F et al. ERA-EDTA registry: renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120-1129.
35. Vesco L, Busson M, Bedrossian J et al. Diabetes mellitus after renal transplantation. Transplantation 1996; 61: 1475-1478.
36. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925-926.
37. Hjelmesæth J, Hartmann A, Midtvedt K et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001; 16: 1047-1052.
38. Davidson J, Wilkinson A, Dantal J et al. International Expert Panel: New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75: SS3-SS24.
39. Stumvoll M, Mitrakou A, Pimenta W et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301.
40. Hjelmesæth J, Midtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation; impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001; 24: 2121-2126.
41. Rollag H, Sagedal S, Holter E et al. Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes. Eur J Clin Microbiol Infect Dis 1998; 17: 124-127.
42. Ljungman P, Griffiths P, Paya C. Definition of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
43. Sagedal S, Nordal KP, Hartmann A et al. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation 2000; 70: 1166-1174.
44. Wu TL, Tsao KC, Chang CP et al. Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta 2002; 322: 163-168.
45. Altman DG. Practical Statistics for Medical Research. Chapman & Hall: London, 1991.